suPAR: The unspecific marker for disease presence, severity and prognosis
- PMID: 26603640
- DOI: 10.1016/j.ijantimicag.2015.10.011
suPAR: The unspecific marker for disease presence, severity and prognosis
Abstract
Investigation of biomarkers that can promptly predict unfavourable outcome of critically illness is an emerging necessity taking into consideration the need for early intervention, the shortage of available beds in intensive care units and the considerable cost of hospitalisation. The most promising biomarker is soluble urokinase-type plasminogen activator receptor (suPAR). Three studies in large populations of critically ill patients and patients admitted to the emergency department have shown that concentrations >12 ng/mL can safely predict unfavourable outcome. This review presents a thorough analysis of the data from these studies.
Keywords: Biomarker; Prognosis; suPAR.
Copyright © 2015 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
